Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevalence and Incidence of Antibodies Against SARS-CoV-2 Among Primary Healthcare Providers in Belgium During One Year of the COVID-19 Epidemic

NCT04779424 is registered in ClinicalTrials.gov with Universiteit Antwerpen as lead sponsor.

NCT NCT04779424
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04779424 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevalence and Incidence of Antibodies Against SARS-CoV-2 Among Primary Healthcare Providers in Belgium During One Year of the COVID-19 Epidemic
Lead sponsor
Universiteit Antwerpen
Phase
Observational
Overall status
Completed
Start date
November 15, 2020
Completion date
March 31, 2023
Enrollment
3,390 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, sars-cov-2